The treatment strategy was changed in 89.2% cases of positive PET/CT scans which shows us that 18F-FDG PET/CT imaging should be integrated into the follow-up programs for DTC patients. highlight the fact that this management changes could include the avoidance of surgical procedures or biopsies, further workup with imaging studies or initiation of unnecessary treatment such as external beam therapy or TKI therapy in the cases of advanced disease. those cases of thyroid recurrence/metastases with elevated Tg levels and unfavorable I-131 WBS. The treatment strategy was changed in 89.2% cases of positive PET/CT scans which shows us that 18F-FDG PET/CT imaging should be integrated into the follow-up programs for DTC patients. emphasize the fact that this management changes could include the avoidance of surgical procedures or biopsies, further workup with imaging studies or initiation of unnecessary treatment such as external beam therapy or TKI therapy in the cases of advanced disease. In the same paper, it is pointed out that positive 18F-FDG PET/CT findings switch the patient management in 20-40% of cases (16). Taking into consideration the results of our study, we have shown that F18-FDG PET/CT is a useful method in detecting tumour recurrence or other metastases despite the fact that we did not find a statistically significant correlation between Tg levels and SUVlbm and just a direct proportional linear correlation was associated, we found a correlation between SUVlbm and the initial stage of patients which leads to the idea that patients with stage III and IV need special requirements in their follow-up program because of their higher risk of recurrence. High metabolic activity highlighted on 18F-FDG PET/CT is associated with a poorly differentiated follicular cell which has lost the ability to concentrate RAI and progressively enhance glucose metabolism due to the high cell activity; in this way PET/CT became a powerful diagnostic method of investigation for undifferentiated lesions. In our study, the cases of aggressive variants such as insular, diffuse sclerosing variants of papillary or follicular Hurthle cell carcinoma was rare, and that is why only a number of 5 patient were referred for external radiation beam and TKI therapy. Even if the 18F-FDG PET/CT studies were performed under optimal conditions there are a high number of negative studies despite the elevated Tg levels. According to Robbins these categories of patients should be integrated into a group of patients where the lack of FDG uptake is related to a lower aggressiveness and slow progression of the disease (17,18). In our study, the patients with unfavorable 18F-FDG PET/CT scans continue to be followed-up and medical decisions were adopted according to the medical history of each patient. In conclusion, in the opinion of the authors, 18F-FDG PET/CT imaging has the capability of identifying cases of tumour recurrence/metastases in the situations where other imaging methods are unfavorable, including I-131 WBS and elevated Tg levels. Normally, this study showed that 18F-FDG PET/CT uptake was associated with advanced stages of the disease and the clinical management was changed in 89.2% cases of positive PET/CT scan which leads to the idea that 18F-FDG PET/CT imaging should be integrated into the follow-up programs of patients with DTC. Discord of interest No author has any potential discord of interest associated with this research..In our study, the cases of aggressive variants such as insular, diffuse sclerosing variants of papillary or follicular Hurthle cell carcinoma was rare, and that is why only a number of 5 patient were referred for external radiation beam and TKI therapy. Even if the 18F-FDG PET/CT studies were performed under optimal conditions there are a high number of negative studies despite the elevated Tg levels. imaging technique which has the capability of identifying those cases of thyroid recurrence/metastases with elevated Tg levels and unfavorable I-131 WBS. The treatment strategy was changed in 89.2% cases of positive PET/CT scans which shows us that 18F-FDG PET/CT imaging should be integrated into the follow-up programs for DTC patients. emphasize the fact that the management changes could include the avoidance of surgical procedures or biopsies, further workup with imaging studies or initiation of unnecessary treatment such as external beam therapy or TKI therapy in the cases of advanced disease. In the same paper, it really is stated that positive 18F-FDG Family pet/CT findings modification the patient administration in 20-40% of instances (16). Considering the outcomes of our research, we have demonstrated that F18-FDG Family pet/CT is a good method in discovering tumour recurrence or additional metastases even though we didn’t look for a statistically significant relationship between Tg amounts and SUVlbm and only a immediate proportional linear relationship was connected, we discovered a relationship between SUVlbm and the original stage of individuals that leads to the theory that individuals with stage III and IV want special requirements within their follow-up system for their higher threat of recurrence. Large metabolic activity highlighted on 18F-FDG Family pet/CT is connected with a badly differentiated follicular cell which includes lost the capability to focus RAI and gradually enhance glucose rate PF-AKT400 of metabolism because of the high cell activity; in this manner Family pet/CT became a robust diagnostic approach to analysis for undifferentiated lesions. Inside our research, the instances of aggressive variations such as for example insular, diffuse sclerosing variations of papillary or follicular Hurthle cell carcinoma was uncommon, and that’s the reason only several 5 patient had been referred for exterior rays beam and VEGFA TKI therapy. Actually if the 18F-FDG Family pet/CT studies had been performed under ideal conditions there are always a lot of negative research despite the raised Tg amounts. Relating to Robbins these types of patients ought to be integrated into several patients where in fact the insufficient FDG uptake relates to PF-AKT400 a lesser aggressiveness and sluggish progression of the condition (17,18). Inside our research, the individuals with adverse 18F-FDG Family pet/CT scans continue being followed-up and medical decisions had been adopted based on the medical history of every patient. To conclude, in the opinion from the authors, 18F-FDG PF-AKT400 Family pet/CT imaging gets the capability of determining instances of tumour recurrence/metastases in the circumstances where additional imaging strategies are adverse, including I-131 WBS and raised Tg amounts. Otherwise, this research demonstrated that 18F-FDG Family pet/CT uptake was connected with advanced phases of the condition and the medical management was transformed in 89.2% instances of positive Family pet/CT scan that leads to the theory that 18F-FDG Family pet/CT imaging ought to be built-into the follow-up applications of individuals with DTC. Turmoil appealing No author offers any potential turmoil appealing connected with this research..
Categories